ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 994,72
-0,16%
Dow Jones
44 747,63
0,00%
DAX
21 902,65
-0,05%
Brent Oil
74,625
0,62%
Bitcoin
98 010,13
1,49%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. RxSight Inc (RXST) Cours

RxSight Inc

RxSight Inc (RXST)

NASDAQ
33,57
-0,69
(-2,01%)
Fermé 07 Février 10:00PM
Retardé de 15 minutes
33,57
0,00
( 0,00% )
Avant marché: 1:00PM
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
33,57
Prix Achat
30,30
Prix Vente
34,99
Volume échangé
9
0,00 Fourchette du Jour 0,00
26,29 Plage de 52 semaines 67,60
Cap du marché
1,353B
Clôture Veille
33,57
Ouverture
-
Dernière Transaction
1
@
34.5
Dernière heure de transaction
10:33:21
Volume financier
-
VWAP
-
Volume moyen (3 m)
680 922
Actions en circulation
40 304 465
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-27,84
Bénéfice par action (BPA)
-1,21
Chiffre d'affairess
89,08M
Bénéfice net
-48,61M

À propos de RxSight Inc

RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery.

Secteur
Ophthalmic Goods
Industrie
Ophthalmic Goods
Site Web
www.rxsight.com
Siège social
Wilmington, Delaware, USA
Fondé
-
RxSight Inc est coté dans le secteur Ophthalmic Goods de la NASDAQ avec le ticker RXST. Le dernier cours de clôture d'RxSight était de US$33,57. Au cours de la dernière année, les actions de RxSight ont été négociées dans une fourchette de prix de US$ 26,29 à US$ 67,60.

RxSight compte actuellement 40 304 465 actions en circulation. La capitalisation boursière d'RxSight est de US$1,35 milliard. RxSight a un ratio cours/bénéfice (ratio PE) de -27.84.

RXST Dernières nouvelles

Plus de nouvelles

Form 4 - Statement of changes in beneficial ownership of securities

27 Janvier 2025
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

22 Janvier 2025
Edgar (US Regulatory)

RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance

ALISO VIEJO, Calif., Jan. 12, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients...

12 Janvier 2025
GlobeNewswire Inc.

RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference

ALISO VIEJO, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients...

02 Janvier 2025
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

04 Décembre 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

29 Novembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

27 Novembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

27 Novembre 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

26 Novembre 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

26 Novembre 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.571.727272727273334.713249181933.83892824CS
4-0.47-1.3807285546434.0434.7126.2968972231.98557422CS
12-11.03-24.73094170444.647.8926.2968092236.52510211CS
26-13.92-29.311433986147.4958.2326.2956960243.3820576CS
52-14.15-29.652137468647.7267.626.2952857147.95312305CS
15622.86213.44537815110.7167.69.5934832637.21139985CS
26016.0791.828571428617.567.68.831460935.81283977CS

RXST - Frequently Asked Questions (FAQ)

What is the current RxSight share price?
The current share price of RxSight is US$ 33,57
How many RxSight shares are in issue?
RxSight has 40 304 465 shares in issue
What is the market cap of RxSight?
The market capitalisation of RxSight is USD 1,35B
What is the 1 year trading range for RxSight share price?
RxSight has traded in the range of US$ 26,29 to US$ 67,60 during the past year
What is the PE ratio of RxSight?
The price to earnings ratio of RxSight is -27,84
What is the cash to sales ratio of RxSight?
The cash to sales ratio of RxSight is 15,19
What is the reporting currency for RxSight?
RxSight reports financial results in USD
What is the latest annual turnover for RxSight?
The latest annual turnover of RxSight is USD 89,08M
What is the latest annual profit for RxSight?
The latest annual profit of RxSight is USD -48,61M
What is the registered address of RxSight?
The registered address for RxSight is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the RxSight website address?
The website address for RxSight is www.rxsight.com
Which industry sector does RxSight operate in?
RxSight operates in the OPHTHALMIC GOODS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
MGOLMGO Global Inc
US$ 0,3768
(103,68%)
69,12M
UPCUniverse Pharmaceuticals Inc
US$ 0,274
(70,19%)
58,46M
RANDRand Capital Corporation
US$ 36,74
(59,67%)
7
ZOOZZOOZ Power Ltd
US$ 3,22
(56,31%)
46
LCNBLCNB Corporation
US$ 23,99
(53,00%)
7
BTMDBiote Corporation
US$ 2,07
(-56,96%)
43
ANIKAnika Therapeutics Inc
US$ 8,00
(-55,03%)
20
EDRYEuroDry Ltd
US$ 6,01
(-45,01%)
4
PFCPremier Financial Corporation
US$ 17,01
(-39,89%)
5
AURAAura Biosciences Inc
US$ 5,01
(-37,45%)
23
MGOLMGO Global Inc
US$ 0,3768
(103,68%)
69,12M
UPCUniverse Pharmaceuticals Inc
US$ 0,274
(70,19%)
58,46M
NIVFNewGenIvf Group Ltd
US$ 0,194
(25,08%)
23,89M
LTRYLottery com Inc
US$ 1,88
(33,33%)
18,63M
CYNCYNGN Inc
US$ 0,0625
(-26,12%)
13,49M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
RXST
RxSight
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces